Categories: News

Typenex Medical Awarded Patient Identification Solutions Agreement with Premier, Inc.

CHICAGO, June 8, 2022 /PRNewswire/ — Typenex® Medical LLC, a pioneer in patient identification solutions, has been awarded a three-year group purchasing contract with Premier, Inc., a leading healthcare improvement company. This new agreement, effective as of August 1, 2022, allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier. This includes Typenex Medical’s comprehensive portfolio of medical labels, identification bands, blood bands, and other related products.

 “We look forward to helping Premier members minimize spend and maximize the benefits gained from our high-quality solutions,” said Craig Searls, Director of National Contracting.

With this contract, Premier members can secure enhanced savings, exclusive perks, and conversion rebates. Proudly manufactured in the USA, Typenex Medical’s extensive line of labels and wristbands includes thousands of stock options and tailored offerings. “Our value-driven supplies and services are designed to deliver improved patient safety, optimal efficiency, smart consolidation, and substantial savings,” added Searls.

Premier (NASDAQ: PINC) unites an alliance of more than 4,400 U.S. hospitals and health systems and approximately 225,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost.

About Typenex® Medical, LLC
Typenex® Medical is a medical device and supply company founded by entrepreneur and investor, John Fife. Typenex Medical is committed to connecting with customers to understand their process needs, then delivering tailored products to help streamline workflows. For more information, please visit www.typenex.com.

Contact: Craig Searls
Director, National Contracting and Corporate Accounts
866-897-3639
sales@typenex.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/typenex-medical-awarded-patient-identification-solutions-agreement-with-premier-inc-301563434.html

SOURCE Typenex Medical

Staff

Recent Posts

Health Care AI Initiative Launched by Paragon Health Institute

New initiative will promote AI policies and solutions to transform American health careWASHINGTON, Jan. 12,…

26 minutes ago

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO CUCAMONGA, CA…

26 minutes ago

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

3 hours ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

4 hours ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

18 hours ago